iThera Medical focuses on the development of proprietary MSOT technology for use in preclinical and clinical applications.
iThera Medical has raised $13.8M in total funding. The most recent round was Series D. The last funding was announced in December 2022.
iThera Medical's investors include European Innovation Council, Bayern Kapital, TRUMPF Venture, BayBG Venture Capital, OCCIDENT.
iThera Medical is headquartered in München, Germany.
iThera Medical focuses on the development of proprietary MSOT technology for use in preclinical and clinical applications.
iThera Medical is at the Series D stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"iThera Medical — Funding & Investors." VCBacked, December 21, 2022, https://www.vcbacked.co/company/ithera-medical. Accessed July 19, 2026.
VCBacked. (2022). iThera Medical — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/ithera-medical
{{cite web |title=iThera Medical — Funding & Investors |url=https://www.vcbacked.co/company/ithera-medical |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated